Harnessing MerTK agonism for targeted therapeutics
Phagocytosis plays important roles both in homeostasis and under pathological conditions. Fcγ receptor-mediated phagocytosis has been exploited as an integral mechanism for antibody-based therapies. Unlike Fcγ receptor-mediated phagocytosis, MerTK-mediated phagocytic clearance is immunologically sil...
Saved in:
Main Authors: | Vivekananda Kedage (Author), Diego Ellerman (Author), Yongmei Chen (Author), Wei-Ching Liang (Author), Joven Borneo (Author), Yan Wu (Author), Minhong Yan (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CLEC5a-directed bispecific antibody for effective cellular phagocytosis
by: Vivekananda Kedage, et al.
Published: (2022) -
Ginsenoside Rg3 Attenuates Lipopolysaccharide-Induced Acute Lung Injury via MerTK-Dependent Activation of the PI3K/AKT/mTOR Pathway
by: Jing Yang, et al.
Published: (2018) -
Targeted IgMs agonize ocular targets with extended vitreal exposure
by: Yvonne Chen, et al.
Published: (2020) -
Targeting the GIPR for obesity: To agonize or antagonize? Potential mechanisms
by: Jonathan E. Campbell
Published: (2021) -
MERTK Inhibition: Potential as a Treatment Strategy in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer
by: Chao-Ju Chen, et al.
Published: (2021)